Literature DB >> 25919654

Intestinal cytomegalovirus infection in patients hospitalized for exacerbation of inflammatory bowel disease: a 10-year tertiary referral center experience.

Annika Gauss1, Simon Rosenstiel, Paul Schnitzler, Ulf Hinz, Tobias Rehlen, Martina Kadmon, Robert Ehehalt, Wolfgang Stremmel, Anna Zawierucha.   

Abstract

OBJECTIVES: This 10-year retrospective cohort study aims to determine the prevalence and risk factors of cytomegalovirus (CMV) infection in inpatients with exacerbated inflammatory bowel disease (IBD).
METHODS: All patients admitted to the Department of Gastroenterology of the University Hospital Heidelberg for IBD exacerbation between January 2004 and June 2013 were enrolled. To identify the risk factors of CMV infection, infected individuals were compared with those with excluded infection.
RESULTS: Among 297 patients with exacerbated IBD, 21 had confirmed CMV infection and 79 had excluded CMV infection, whereas the remaining patients had not been sufficiently tested for CMV. Taking into account only sufficiently tested individuals, the prevalence of CMV infection was 22.7% in ulcerative colitis and 16.0% in Crohn's disease. The occurrence of CMV infection was associated with the following variables at admission: age of 30 years or more [odds ratio (OR) 14.29; P=0.004], disease duration less than 60 months (OR 7.69; P=0.011), a blood leukocyte count less than 11/nl (OR 4.49; P=0.041), and immunosuppressive therapy (OR 6.73; P=0.0129). CMV-positive patients remained in the hospital longer than noninfected patients (P=0.0009). In the CMV-positive cohort, a 66-year-old woman died of CMV pneumonia and sepsis, whereas there was no death in the CMV-negative cohort.
CONCLUSION: Immunuosuppressive therapy and age older than 30 years were identified as the main risk factors for the development of CMV infection in exacerbated IBD. Because of the risk of death, diagnostics of CMV infection should especially be initiated in older patients on immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25919654     DOI: 10.1097/MEG.0000000000000361

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  7 in total

Review 1.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 2.  CMV Infection in Pediatric IBD.

Authors:  Anat Yerushalmy-Feler; Sharona Kern-Isaacs; Shlomi Cohen
Journal:  Curr Gastroenterol Rep       Date:  2018-03-28

Review 3.  Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.

Authors:  Sylvie Pillet; Bruno Pozzetto; Xavier Roblin
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

4.  Cytomegalovirus infection is associated with worse outcomes in inflammatory bowel disease hospitalizations nationwide.

Authors:  Steven A Hendler; Grant E Barber; Philip N Okafor; Matthew S Chang; David Limsui; Berkeley N Limketkai
Journal:  Int J Colorectal Dis       Date:  2020-03-02       Impact factor: 2.571

5.  Colitis due to Cytomegalovirus and Herpes Simplex Type 2 as a Complication of a First Presentation of Inflammatory Bowel Disease.

Authors:  Tiago Leal; Bruno Arroja; Dalila Costa; Carla Ferreira; João Bruno Soares; Raquel Gonçalves
Journal:  GE Port J Gastroenterol       Date:  2021-03-23

Review 6.  Approach to cytomegalovirus infections in patients with ulcerative colitis.

Authors:  Sung Chul Park; Yoon Mi Jeen; Yoon Tae Jeen
Journal:  Korean J Intern Med       Date:  2017-04-20       Impact factor: 2.884

7.  Cytomegalovirus colitis in hospitalized inflammatory bowel disease patients in Taiwan: a referral center study.

Authors:  Meng-Tzu Weng; Chien-Chih Tung; Yi-Shuan Lee; Yew-Loong Leong; Ming-Jium Shieh; Chia-Tung Shun; Cheng-Yi Wang; Jau-Min Wong; Shu-Chen Wei
Journal:  BMC Gastroenterol       Date:  2017-02-13       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.